Carna Biosciences (TSE:4572) FCF Yield %: -33.25 (As of Jun. 30, 2026)


TSE:4572 Carna Biosciences Inc TSE:4572
24 GF Score
Price 円340.00
GF Value 円175.60
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Carna Biosciences FCF Yield %?

Carna Biosciences TSE:4572 +6.92% 24 FCF Yield % is -33.25 as of Jun. 30, 2026. GuruFocus rates TSE:4572 with a GF Score™ of 24/100 and a GF Value™ of 円175.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,415 Biotechnology companies, Carna Biosciences ranks worse than 78.37% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Carna Biosciences's Trailing 12-Month Free Cash Flow is 円-2,168.6 Mil, and Market Cap is 円6,523.1 Mil. Therefore, Carna Biosciences's FCF Yield % for today is -33.25%.

The historical rank and industry rank for Carna Biosciences's FCF Yield % or its related term are showing as below:

TSE:4572' s FCF Yield % Range Over the Past 10 Years
Min: -36   Med: 0   Max: 0
Current: -33.25


TSE:4572's FCF Yield % is ranked worse than
78.37% of 1415 companies
in the Biotechnology industry
Industry Median: -9.49 vs TSE:4572: -33.25

Carna Biosciences's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.


Carna Biosciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Carna Biosciences FCF Yield % Related Terms


Carna Biosciences FCF Yield % Historical Data

* Premium members only.

The historical data trend for Carna Biosciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carna Biosciences FCF Yield % Chart

Carna Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.76 -11.29 -18.87 -24.23 -31.83

Carna Biosciences Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Dec25 Mar26
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:4572 vs VRTX, REGN, ALNY: FCF Yield % Comparison

For the Biotechnology subindustry, Carna Biosciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carna Biosciences FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Carna Biosciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Carna Biosciences's FCF Yield % falls into.


TSE:4572
24GF Score
Carna Biosciences Inc TSE:4572
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carna Biosciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Carna Biosciences's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-2168.643 / 6813.484
=-31.83%

Carna Biosciences's annualized FCF Yield % for the quarter that ended in Dec. 2025 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=0 * 4 / 6813.484
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -33.25 mean?
Carna Biosciences (TSE:4572) has a FCF Yield % of -33.25 as of Jun. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Carna Biosciences and its competitors. According to the industry distribution chart, Carna Biosciences ranks #1109 out of 1415 companies in the Biotechnology industry, placing it in the top 78.4%.
Is Carna Biosciences' FCF Yield % too high?
Carna Biosciences' current FCF Yield % is -33.25. Based on the distribution chart, Carna Biosciences ranks #1109 out of 1415 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Carna Biosciences has a GF Score™ of 24/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Carna Biosciences ranks #1109 out of 1415 companies for FCF Yield %. This places Carna Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Carna Biosciences and its competitors. Carna Biosciences's current FCF Yield % is -33.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円175.60, compared to a current price of 円340.00 — trading 93.6% above its estimated fair value. The current FCF Yield % is -33.25. Carna Biosciences' overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current FCF Yield % is -33.25 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Carna Biosciences (TSE:4572) Overvalued in 2026?

Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued. The current stock price of 円340.00 is trading 93.6% above its estimated GF Value™ of 円175.60. GuruFocus considers Carna Biosciences to be Significantly Overvalued.

Key valuation signals for TSE:4572:

  • FCF Yield %: -33.25
  • GF Value™: 円175.60 vs. price of 円340.00 (93.6% above fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carna Biosciences Business Description

Address BMA 3F 1-5-5 Minatojima-Minamimachi, Kobe, JPN, 650-0047
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
24GF Score

Get the complete analysis for TSE:4572

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円340.00
Price
円175.60
GF Value